Related Experiment Videos

Adverse drug reactions in hospitalized children in Fortaleza, Brazil

Djanilson Barbosa dos Santos1, Helena Lutéscia Luna Coelho

  • 1Master in Clinical Pharmacy, Federal University of Ceara, Fortaleza, Ceara, Brazil. dejab@bol.com.br

Insights

Adverse drug reactions (ADRs) occurred in 12.5% of hospitalized children, with risk factors including multiple medications and prior hospitalizations. Most ADRs were mild and skin-related, often linked to systemic antibiotics.

Area of Science:

  • Pediatric pharmacology
  • Clinical pharmacy
  • Drug safety surveillance

Background:

  • Adverse drug reactions (ADRs) pose a significant risk in pediatric hospital settings.
  • Understanding ADR occurrence and risk factors is crucial for patient safety.

Purpose of the Study:

  • To investigate the incidence and risk factors of ADRs in hospitalized children.
  • To analyze drug-related events in a pediatric hospital in northeast Brazil.

Main Methods:

  • Prospective cohort study involving 272 pediatric patients hospitalized for over 24 hours.
  • Daily monitoring for drug prescriptions, medical events, and adverse events.
  • Utilized WHO categories for assessing ADR imputability and severity.

Main Results:

  • ADRs were detected in 12.5% of 265 children exposed to medications.
  • Systemic antibiotics were the most implicated drug class (53.2%), with skin reactions being most common (49%).
  • Increased risk of ADRs was associated with multiple drug use, male gender, and previous hospitalizations.

Conclusions:

  • ADRs are a notable concern in hospitalized pediatric populations.
  • Children with a history of hospitalizations and polypharmacy are at higher risk for ADRs.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...